LV12624B - Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana - Google Patents
Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusanaInfo
- Publication number
- LV12624B LV12624B LV000135A LV000135A LV12624B LV 12624 B LV12624 B LV 12624B LV 000135 A LV000135 A LV 000135A LV 000135 A LV000135 A LV 000135A LV 12624 B LV12624 B LV 12624B
- Authority
- LV
- Latvia
- Prior art keywords
- thienylazolylalkosietanamines
- legusana
- drug
- application
- drug legusana
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES009800793A ES2150353B1 (es) | 1998-04-15 | 1998-04-15 | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos. |
| PCT/ES1999/000098 WO1999052525A1 (es) | 1998-04-15 | 1999-04-15 | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV12624A LV12624A (lv) | 2001-03-20 |
| LV12624B true LV12624B (lv) | 2001-09-20 |
Family
ID=8303465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LV000135A LV12624B (lv) | 1998-04-15 | 2000-11-03 | Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US6410582B1 (is) |
| EP (1) | EP1072266B8 (is) |
| JP (1) | JP2002511412A (is) |
| KR (1) | KR100523366B1 (is) |
| CN (1) | CN1189170C (is) |
| AR (1) | AR016210A1 (is) |
| AT (1) | ATE302604T1 (is) |
| AU (1) | AU754705B2 (is) |
| BG (1) | BG64891B1 (is) |
| BR (1) | BR9910124A (is) |
| CA (1) | CA2328878A1 (is) |
| CO (1) | CO5011045A1 (is) |
| CU (1) | CU22960A3 (is) |
| CZ (1) | CZ298222B6 (is) |
| EE (1) | EE04739B1 (is) |
| ES (1) | ES2150353B1 (is) |
| GE (1) | GEP20032913B (is) |
| HU (1) | HUP0102585A3 (is) |
| IS (1) | IS5662A (is) |
| LT (1) | LT4830B (is) |
| LV (1) | LV12624B (is) |
| NO (1) | NO320313B1 (is) |
| NZ (1) | NZ507573A (is) |
| PL (1) | PL343512A1 (is) |
| RO (1) | RO121690B1 (is) |
| RU (1) | RU2213743C2 (is) |
| SI (1) | SI20473A (is) |
| SK (1) | SK285039B6 (is) |
| TW (1) | TW528756B (is) |
| UA (1) | UA58589C2 (is) |
| WO (1) | WO1999052525A1 (is) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2150353B1 (es) * | 1998-04-15 | 2001-07-01 | Esteve Labor Dr | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos. |
| ES2137136B1 (es) * | 1998-05-18 | 2000-07-01 | Esteve Labor Dr | Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica. |
| ES2150378B1 (es) * | 1998-08-07 | 2001-07-01 | Esteve Labor Dr | Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p. |
| US6432954B1 (en) * | 2000-07-14 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| ES2174756B2 (es) * | 2001-04-06 | 2003-11-16 | Esteve Labor Dr | Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias. |
| ES2180449B1 (es) * | 2001-07-06 | 2004-01-16 | Esteve Labor Dr | Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria. |
| US20040142929A1 (en) * | 2001-07-06 | 2004-07-22 | Ramon Merce-Vidal | Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence |
| CL2004001034A1 (es) | 2003-05-14 | 2005-03-28 | Teijin Pharma Ltd | Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r |
| TW200533657A (en) * | 2004-02-17 | 2005-10-16 | Esteve Labor Dr | Substituted pyrazoline compounds, their preparation and use as medicaments |
| EP1584335A3 (en) * | 2004-04-05 | 2006-02-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising a carbinol composition and an opioid |
| US20060040924A1 (en) * | 2004-06-22 | 2006-02-23 | Laboratorios Dr. Esteve S.A. | Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic |
| WO2006010627A1 (en) * | 2004-07-30 | 2006-02-02 | Laboratorios Del Dr. Esteve, S.A. | Aryl (or heteroaryl) azolylcarbinols |
| EP1632227A1 (en) * | 2004-09-07 | 2006-03-08 | Laboratorios del Dr. Esteve S.A. | Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction |
| EP1671968A1 (en) | 2004-12-17 | 2006-06-21 | Laboratorios Del Dr. Esteve, S.A. | Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
| EP1828175A2 (en) * | 2004-12-17 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
| ES2303795B1 (es) * | 2004-12-27 | 2009-06-12 | Laboratorios Del Dr. Esteve, S.A. | Procedimiento para obtener enantiomeros de tienilazolilalcoxietanaminas. |
| WO2006069767A1 (en) * | 2004-12-27 | 2006-07-06 | Laboratorios Del Dr. Esteve, S.A. | Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
| EP1674465A1 (en) | 2004-12-27 | 2006-06-28 | Laboratorios Del Dr. Esteve, S.A. | Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
| EP1743890A1 (en) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments |
| EP1743892A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios del Dr. Esteve S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
| US7897589B2 (en) * | 2005-07-15 | 2011-03-01 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
| EP1757587A1 (en) * | 2005-07-15 | 2007-02-28 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
| US20070149590A1 (en) * | 2005-08-05 | 2007-06-28 | Garcia Francisco J L | Controlled release dosage form of pirazole compounds |
| EP1820502A1 (en) | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising azolylcarbinol compounds |
| EP2151234A1 (en) * | 2008-07-28 | 2010-02-10 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion |
| CN102432845B (zh) * | 2011-08-22 | 2013-03-13 | 电子科技大学 | 聚3,4-双乙基羟基噻吩气敏材料及其制备方法 |
| EP3233805B1 (en) | 2014-12-15 | 2019-02-06 | Esteve Pharmaceuticals, S.A. | Methyl-1h-pyrazole-alkylamine compounds having multimodal activity against pain |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2613720B1 (fr) * | 1987-04-10 | 1990-01-19 | Esteve Labor Dr | Derives d'aryl-heteroaryl carbinols avec activite analgesique |
| ES2150353B1 (es) * | 1998-04-15 | 2001-07-01 | Esteve Labor Dr | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos. |
| ES2137136B1 (es) * | 1998-05-18 | 2000-07-01 | Esteve Labor Dr | Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica. |
-
1998
- 1998-04-15 ES ES009800793A patent/ES2150353B1/es not_active Expired - Fee Related
-
1999
- 1999-04-14 CO CO99022015A patent/CO5011045A1/es unknown
- 1999-04-14 AR ARP990101712A patent/AR016210A1/es unknown
- 1999-04-15 EE EEP200000596A patent/EE04739B1/xx not_active IP Right Cessation
- 1999-04-15 PL PL99343512A patent/PL343512A1/xx not_active IP Right Cessation
- 1999-04-15 JP JP2000543135A patent/JP2002511412A/ja active Pending
- 1999-04-15 KR KR10-2000-7011466A patent/KR100523366B1/ko not_active IP Right Cessation
- 1999-04-15 SI SI9920030A patent/SI20473A/sl not_active IP Right Cessation
- 1999-04-15 HU HU0102585A patent/HUP0102585A3/hu unknown
- 1999-04-15 SK SK1528-2000A patent/SK285039B6/sk unknown
- 1999-04-15 CZ CZ20003764A patent/CZ298222B6/cs not_active IP Right Cessation
- 1999-04-15 CA CA002328878A patent/CA2328878A1/en not_active Abandoned
- 1999-04-15 RO ROA200000995A patent/RO121690B1/ro unknown
- 1999-04-15 GE GEAP19995625A patent/GEP20032913B/en unknown
- 1999-04-15 EP EP99913321A patent/EP1072266B8/en not_active Expired - Lifetime
- 1999-04-15 US US09/673,186 patent/US6410582B1/en not_active Expired - Fee Related
- 1999-04-15 NZ NZ507573A patent/NZ507573A/en unknown
- 1999-04-15 AT AT99913321T patent/ATE302604T1/de not_active IP Right Cessation
- 1999-04-15 UA UA2000105809A patent/UA58589C2/uk unknown
- 1999-04-15 RU RU2000128658/04A patent/RU2213743C2/ru not_active IP Right Cessation
- 1999-04-15 BR BR9910124-6A patent/BR9910124A/pt not_active Application Discontinuation
- 1999-04-15 CN CNB998068098A patent/CN1189170C/zh not_active Expired - Fee Related
- 1999-04-15 AU AU31483/99A patent/AU754705B2/en not_active Ceased
- 1999-04-15 WO PCT/ES1999/000098 patent/WO1999052525A1/es active IP Right Grant
- 1999-04-19 TW TW088106199A patent/TW528756B/zh not_active IP Right Cessation
-
2000
- 2000-10-09 CU CU20000215A patent/CU22960A3/es unknown
- 2000-10-12 LT LT2000097A patent/LT4830B/lt unknown
- 2000-10-13 NO NO20005146A patent/NO320313B1/no not_active IP Right Cessation
- 2000-10-13 IS IS5662A patent/IS5662A/is unknown
- 2000-10-13 BG BG104853A patent/BG64891B1/bg unknown
- 2000-11-03 LV LV000135A patent/LV12624B/xx unknown
-
2002
- 2002-05-06 US US10/139,674 patent/US20020188017A1/en not_active Abandoned
-
2004
- 2004-02-13 US US10/779,287 patent/US7129361B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV12624B (lv) | Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana | |
| ID23874A (id) | Obat | |
| NO20005913L (no) | Legemiddelsammensetning | |
| FI971279A (fi) | Lääkkeitä | |
| ID24555A (id) | Popok sekali pakai | |
| ID27415A (id) | Komposisi farmaseutik | |
| ID23076A (id) | Popok sekali pakai | |
| NO20011085D0 (no) | Tablett med umiddelbar frigivningsvirkning | |
| ID29089A (id) | Sediaan farmasi moksifloksasin | |
| ID29262A (id) | Komposisi farmasi | |
| NO992692D0 (no) | Nefadozon doseringsform | |
| ID27201A (id) | Komposisi farmasi | |
| DK1017392T3 (da) | Lægemiddel | |
| ID27150A (id) | Sediaan levotiroksin bahan farmasi | |
| ID29294A (id) | Komposisi farmasi | |
| ID25857A (id) | Komposisi farmasi | |
| EA199900672A1 (ru) | Гомеопатическое лекарственное средство | |
| ID26215A (id) | Komposisi farmasi | |
| EA199900673A1 (ru) | Гомеопатическое лекарственное средство | |
| ATE238786T1 (de) | Anti-first-pass-effect-substanzen | |
| PT1235809E (pt) | 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocinas substituidas e sua utilizacao como medicamentos | |
| ID23531A (id) | Komposisi farmasi | |
| FI972010A0 (fi) | Arrangemang i en borrningsanordning | |
| SE9803771D0 (sv) | Pharmaceutical composition and use | |
| SE9703737D0 (sv) | Pharmaceutical composition and use |